Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 3/20 | 0.57 |
| ▸ | BACE1 | P56817 | 8/20 | 0.54 |
| ▸ | BACE2 | Q9Y5Z0 | 4/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.51 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.51 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30385341 | 0.95 | BACE1 (0.58) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL29611583 | 0.94 | NPY1R (0.52) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL30570969 | 0.93 | OPRD1 (0.56) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL29612192 | 0.93 | OPRD1 (0.51) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL29611329 | 0.93 | CASP1 (0.55) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL30974007 | 0.93 | ERAP2 (0.52) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL30123028 | 0.93 | OPRD1 (0.54) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL30973962 | 0.92 | OPRD1 (0.61) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL30918769 | 0.92 | OPRD1 (0.58) | OPRD1BACE1BACE2NPY1RNPY2R | |
| SCHEMBL11040848 | 0.92 | OPRK1 (0.54) | OPRD1NPY1RNPY2RNPY4RERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | TYR, TELO2, MTX2 | OPRD1 3556/4885BACE1 3288/4885BACE2 3110/4885 |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, TELO2, MTX2 | OPRD1 3556/4885BACE1 3288/4885BACE2 3110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.